Cargando…
The therapeutic potential of HIF-2 antagonism in renal cell carcinoma
Hypoxia, the insufficient delivery of oxygen for the demand of a tissue, contributes to the development of an aggressive phenotype, resistance to radiation therapy and chemotherapy, and is predictive of a poor outcome in numerous tumor types. Adaptation to hypoxia is mediated by hypoxia-inducible fa...
Autor principal: | Cuvillier, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313304/ https://www.ncbi.nlm.nih.gov/pubmed/28217462 http://dx.doi.org/10.21037/tau.2017.01.12 |
Ejemplares similares
-
HIF1A predicts the efficacy of anti-PD-1 therapy in advanced clear cell renal cell carcinoma
por: Guo, Tuanjie, et al.
Publicado: (2022) -
P2X7 receptor antagonism in amyotrophic lateral sclerosis
por: Sluyter, Ronald, et al.
Publicado: (2017) -
The Siah2-HIF-FoxA2 axis in prostate cancer – new markers and therapeutic opportunities
por: Qi, Jianfei, et al.
Publicado: (2010) -
The Gut Microbiome and Metastatic Renal Cell Carcinoma
por: Meza, Luis, et al.
Publicado: (2023) -
Regulation of Osteogenesis-Angiogenesis Coupling by HIFs and VEGF
por: Schipani, Ernestina, et al.
Publicado: (2009)